Mark Casey J.'s most recent trade in Novavax, Inc. was a trade of 169,000 2025 Non-statutory Stock Option NQ done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax, Inc. | Mark J. Casey | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 169,000 | 169,000 | - | - | 2025 Non-statutory Stock Option NQ | |
| Novavax, Inc. | Mark J. Casey | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 112,500 | 112,500 | - | - | 2025 Restricted Stock Units RSU | |
| Novavax, Inc. | Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 4,000 | 33,187 (0%) | 0% | 0 | Common Stock | |
| Novavax, Inc. | Mark J. Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 4,000 | 8,000 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Mark J. Casey | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 01 Mar 2025 | 1,214 | 31,973 (0%) | 0% | 8.3 | 10,113 | Common Stock |
| Novavax, Inc. | Mark Casey J. | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 41,900 | 83,798 | - | - | Restricted Stock Units | |
| Novavax, Inc. | J. Mark Casey | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 41,900 | 41,900 (0%) | 0% | 0 | Common Stock | |
| Novavax, Inc. | Casey Mark J. | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.82 per share. | 11 Dec 2024 | 12,713 | 29,187 (0%) | 0% | 8.8 | 112,129 | Common Stock |
| Novavax, Inc. | Mark J. Casey | EVP, CLO & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,000 | 12,000 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Mark Casey J. | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 144,694 | 144,694 | - | - | Stock Options (Right to buy) | |
| Novavax, Inc. | Casey Mark J. | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 125,698 | 125,698 | - | - | Restricted Stock Units |